APA (7th ed.) Citation

Xu, L., Shadman, M., Flinn, I. W., Levy, M. Y., Porter, R., Burke, J. M., . . . Ramakrishnan, V. (2024). Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies. Haematologica (Roma), 109(7), 2284-2289. https://doi.org/10.3324/haematol.2023.283861

Chicago Style (17th ed.) Citation

Xu, Linlin, et al. "Genomic Landscape of Patients in a Phase II Study of Zanubrutinib in Ibrutinib- And/or Acalabrutinib-intolerant Patients with B-cell Malignancies." Haematologica (Roma) 109, no. 7 (2024): 2284-2289. https://doi.org/10.3324/haematol.2023.283861.

MLA (9th ed.) Citation

Xu, Linlin, et al. "Genomic Landscape of Patients in a Phase II Study of Zanubrutinib in Ibrutinib- And/or Acalabrutinib-intolerant Patients with B-cell Malignancies." Haematologica (Roma), vol. 109, no. 7, 2024, pp. 2284-2289, https://doi.org/10.3324/haematol.2023.283861.